What is the recommended treatment for Tinea pedis (athlete's foot)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Pedis (Athlete's Foot)

Topical terbinafine 1% cream applied twice daily for 1 week is the most effective first-line treatment for tinea pedis, achieving superior cure rates compared to longer courses of other antifungal agents. 1, 2

First-Line Treatment Options

  • For interdigital tinea pedis (between the toes), apply terbinafine 1% cream twice daily for 1 week 1, 2
  • For tinea pedis on the bottom or sides of the foot, apply terbinafine 1% cream twice daily for 2 weeks 2
  • Terbinafine offers a fungicidal mode of action, resulting in higher cure rates and shorter treatment duration compared to fungistatic alternatives 3
  • Clinical studies show terbinafine 1% cream applied twice daily for 1 week is significantly more effective than clotrimazole 1% cream applied twice daily for 4 weeks (89.7% vs 58.7% effective treatment rate) 4

Alternative Topical Options

  • Ciclopirox olamine 0.77% cream/gel applied twice daily for 4 weeks achieves approximately 60% clinical and mycological cure at end of treatment, and 85% two weeks after treatment 5, 1
  • Clotrimazole 1% cream applied twice daily for 4 weeks is less effective than terbinafine but is widely available over-the-counter 1, 4

Oral Therapy for Severe or Resistant Cases

  • Oral terbinafine 250mg once daily for 1 week has similar efficacy to 4 weeks of topical clotrimazole but with faster clinical resolution 5, 1
  • Oral terbinafine is well-tolerated in children, though potential adverse events include occasional isolated neutropenia and rare liver failure (typically in people with preexisting liver disease) 5
  • Oral itraconazole 100mg daily for 2 weeks has similar mycological efficacy to terbinafine but may have a slightly higher relapse rate 5, 1
  • Oral therapy should be reserved for severe disease, failed topical therapy, concomitant onychomycosis, or immunocompromised patients 1, 6

Prevention Measures

  • Apply foot powder after bathing to reduce tinea pedis rates 5, 1
  • Thoroughly dry between toes after showering 5, 1
  • Change socks daily and periodically clean athletic footwear 5, 1
  • Wear well-fitting, ventilated shoes 2
  • To prevent spread to the groin area (tinea cruris), cover active foot lesions with socks before wearing underwear 5, 1

Clinical Considerations

  • Risk factors include swimming, running (especially marathon running), warm humid environments, male gender, obesity, and diabetes 5, 1
  • Causative organisms are predominantly Trichophyton rubrum and Trichophyton mentagrophytes 5, 6
  • Diagnosis should be confirmed with potassium hydroxide (KOH) wet-mount examination of skin scrapings from the active border of the lesion 7, 6
  • Treatment should continue for at least one week after clinical clearing of infection 7
  • Failing to treat all infected family members simultaneously can result in reinfection 1
  • Neglecting to address contaminated footwear as a source of reinfection can lead to recurrence 1

Treatment Algorithm

  1. Mild to moderate tinea pedis:

    • First-line: Terbinafine 1% cream twice daily (1 week for interdigital, 2 weeks for plantar)
    • Alternative: Ciclopirox olamine 0.77% cream twice daily for 4 weeks
  2. Severe, extensive, or resistant cases:

    • Oral terbinafine 250mg once daily for 1 week
    • Alternative: Oral itraconazole 100mg daily for 2 weeks
  3. For all patients:

    • Implement prevention measures
    • Continue treatment until at least 1 week after clinical clearing
    • Address all potential sources of reinfection

References

Guideline

Treatment of Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Topical terbinafine. Reduction of duration of therapy for tinea pedis].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tinea pedis: an updated review.

Drugs in context, 2023

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.